Robbins Farley’s BioNTech BNTX Stock Holding History

Robbins Farley’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-877	Closed	-$118K	–	188
2022 Q3	$118K	Buy	+877	New	+$134K	0.1%	62
2022 Q2	–	Sell	-13,220	Closed	-$2.25M	–	125
2022 Q1	$2.25M	Buy	+13,220	New	+$2.22M	1.7%	30
2021 Q4	–	Sell	-7,721	Closed	-$2.11M	–	158
2021 Q3	$2.11M	Buy	+7,721	New	+$2.45M	1.55%	31
2021 Q2	–	Sell	-3,111	Closed	-$630K	–	99
2021 Q1	$630K	Buy	+3,111	New	+$330K	0.55%	44

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Robbins Farley's BNTX Position: Q4 2022 in Review

Robbins Farley sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 877 shares — an estimated $118K sold.

Robbins Farley first reported a position in BNTX in Q1 2021 and held it in 4 quarters. The position peaked at $2.25M in Q1 2022. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

Robbins Farley reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
Robbins Farley sold 877 BioNTech shares in Q4 2022, an estimated $118K.
Robbins Farley first reported a position in BioNTech in Q1 2021 and held it in 4 quarters.
Robbins Farley's BioNTech position peaked at $2.25M in Q1 2022.
320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Robbins Farley's 13F filing for Q4 2022, filed 7 Feb 2023.